Treatment

Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) experienced a severe drop on Friday, plummeting almost 60% from $52 to $21, as competitor Novo Nordisk (NYSE:NVO) published trial results for monlunabant, a cannabinoid receptor 1 (CB1) inverse agonist. Novo Nordisk shares also traded down roughly 5.5...

Editor’s note: This story has been updated to correct the spelling of Anna-Sophia Kouparanis’ name. Since the legalization of medical cannabis in Germany in 2017, the industry has faced notable challenges, chiefly the scarcity of physicians ready to prescribe these treatments. Anna-...

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk's startup Neuralink brain chip could help treat morbid obesity; that's what Musk believes. Echoing Musk's statement, scientists say it's not an impossibility.  Responding to a Twitter post on the same line, Musk said that it is...

By Rodney Wallace, former pro soccer player and founder of CBD brand Rewind. At first, I was skeptical about sharing my thoughts and giving my opinion on “the Simone Biles  Saga”. The word saga in itself makes it seem as if pulling out of a major Olympic event due to personal...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. The University of California, San Francisco (UCSF) is creating a Neuroscape Psychedelics Division, a multidisciplinary research center to bridge the gap...

It’s sad to say, but it seems like the only time we pay attention to the addiction problem in this country is when someone famous overdoses. Such is the case with DMX, who I would argue is one of the most unique and gifted rappers ever. His abrasive voice, his cut-to-the-bone lyrics, and his...

This article by Tammy Taylor was originally published on Cannabis & Tech Today, and appears here with permission. Depression is an increasingly common health concern. People have often refrained from talking about depression due to the stigma around mental health issues. But, more and more...

This article by Chynna Pearson was originally published on Cannabis & Tech Today, and appears here with permission. Parkinson’s disease is a condition that affects populations all over the globe. In fact, it is estimated that over 10 million people live with the condition...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. United Kingdom-based startup Beckley Psytech is gearing up for a Phase 1 clinical trial investigating a synthetic version of 5-MeO-DMT. The trial is looking at...

This article by Jill Ettinger was originally published on Psychedelic Spotlight, and appears here with permission. New research out of Australia points to the benefits of ketamine therapy in reducing suicidal thoughts. The findings are published in the journal Translational Psychiatry....

By Steven Palmer (a.k.a. Hazey Taughtme). Substance use disorder is one of the most prevalent issues in our society today. So much so that the National Survey on Drug Use and Health (NSDUH) estimates that nearly 20 million Americans have fought a substance abuse issue since 2017. Although substance...

Cannabinoid receptors distributed within the body are part of the endocannabinoid system that largely affects processes such as mood, memory, pain-sensation, and appetite, to name a few. Two types of receptors — CB1 and CB2 — “play a vital role in managing different body...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Canada is poised to become the next country to legalize psychedelic medicine. Last year, Health Canada began expanding access to psilocybin-containing...

This article by Evan Lewis-Healy was originally published on Psychedelic Spotlight, and appears here with permission. Dr. Hyder Khoja is hoping to treat coma patients with psychedelics in order to “jump-start” them back into consciousness. The monumental potential that psychedelics...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. Researchers say psychedelics like ayahuasca, psilocybin, ketamine, ibogaine and 5-MeO-DMT prove so beneficial to professional athletes because they have the ability to...